Recombinant Diploptera punctata Diuretic hormone class 2

What is Diploptera punctata DH31 and how does it differ from other insect diuretic hormones?

Diploptera punctata DH31 (Dippu-DH31) is a 31-amino acid peptide isolated from the cockroach Diploptera punctata that functions as a diuretic hormone. Unlike the corticotropin-releasing factor (CRF)-like diuretic hormones (such as Dippu-DH46), Dippu-DH31 belongs to the calcitonin-like peptide family. It has little sequence similarity to CRF-like diuretic hormones but shows significant homology to vertebrate calcitonin . The peptide increases cAMP production and fluid secretion in Malpighian tubules across several insect species, with an EC50 value of approximately 9.8 nM in D. punctata . Dippu-DH31 represents a distinct evolutionary branch of insect diuretic hormones with properties that differentiate it from previously identified insect peptides with diuretic activity.

What is the structure and sequence of Dippu-DH31?

Dippu-DH31 is a 31-amino acid peptide that shares structural similarities with the calcitonin family of peptides. While the specific sequence isn't provided in the search results, the peptide contains features characteristic of the calcitonin family, including the C-terminal GP-amide motif that is conserved across calcitonin-type molecules . This structural characteristic is evolutionarily ancient, as deuterostomian-type calcitonins (which contain two conserved Cys residues) are present in lophotrochozoans together with DH31-like peptides . Unlike some other peptide hormone families, DH31 appears to be highly conserved across arthropod species, as demonstrated by the fact that DH31 peptides from different species produce essentially identical responses in receptor activation assays .

How are diuretic hormones involved in insect water balance regulation?

In insects, urine production by the Malpighian tubules is driven by hormonally controlled active transport processes, rather than by ultrafiltration as in vertebrates . Diuretic hormones play crucial roles in this regulation, with different families acting through distinct signaling pathways:

• CRF-like diuretic hormones (e.g., Dippu-DH46) - Act via cAMP as a second messenger

• Calcitonin-like diuretic hormones (e.g., Dippu-DH31) - Also signal via cAMP pathways

• Myokinins (e.g., locustakinin) - Increase urine production by elevating intracellular Ca2+

What are the receptor-ligand interactions for Dippu-DH31 and how does this compare across species?

Dippu-DH31 mediates its effects by binding to family B G-protein coupled receptors (GPCRs), specifically secretin receptor family members . These receptors are characterized by:

• High sequence identity in the transmembrane regions

• Conserved extracellular N-terminal region with six conserved Cys residues

• Characteristic potential N-glycosylation sites (four predicted for crab C. maenas)

• Common N-glycosylation motifs (NGTW, NYTT) shared across most DH31 receptors

In heterologous expression systems, DH31 receptors from different arthropod species show varying sensitivity to DH31 peptides. For instance, in the kissing bug Rhodnius prolixus, multiple DH31 receptor splice variants exist, with the R1B isoform activated by much higher concentrations of DH31 (EC50 200-300 nM) than another isoform (15 nM) .

Interestingly, in some insects like Drosophila, the function of DH31 receptors is greatly enhanced by co-expression with receptor component proteins (RCPs) or receptor activity-modifying proteins (RAMPs) . These accessory proteins may act as pharmacological switches, chaperones, and regulators of receptor trafficking. Their absence in heterologous expression systems might explain the modest sensitivity sometimes observed in such assays.

How do Dippu-DH31 and Dippu-DH46 interact synergistically in fluid secretion regulation?

Dippu-DH31 and Dippu-DH46 demonstrate synergistic effects in D. punctata but show only additive effects in Locusta migratoria, indicating species-specific interactions . This synergism suggests a sophisticated regulatory system involving multiple signaling pathways:

• When applied together at their respective EC50 concentrations, the two peptides produce a response in D. punctata that is significantly greater than the sum of their individual effects

• The interaction between these peptides likely involves cross-talk between their signaling pathways, potentially at the level of second messengers (cAMP)

• The synergistic effect allows for more fine-tuned control of diuresis in response to varying physiological demands

Testing for interactions between diuretic peptides from different species reveals additional complexity. In L. migratoria, Dippu-DH31 acts synergistically with both Locmi-K (a myokinin that utilizes Ca2+ as second messenger) and Locmi-DH (a CRF-related peptide that acts via cAMP) . Conversely, Dippu-DH46 synergizes with Locmi-K but has no effect on the response to Locmi-DH . This suggests that the mechanisms underlying peptide interactions are peptide-specific rather than simply pathway-specific.

What are the evolutionary relationships of DH31 peptides across arthropod species?

DH31 represents an evolutionarily ancient signaling molecule with remarkable conservation across arthropod species. Key evolutionary characteristics include:

• Calcitonin-type molecules are present in both deuterostomes and lophotrochozoans, with DH31-like peptides appearing in the latter alongside deuterostomian-type calcitonins

• While insects may have undergone gene duplication for DH31 receptors, crustaceans like Daphnia pulex and Calanus finmarchicus appear to have only single receptor transcripts

• Specialized functions of DH31 receptors have evolved independently in different arthropod lineages - for example, diuresis is mediated through CT/DH-R2 in the hemipteran Rhodnius prolixus but through CT/DH-R1 in dipterans like Drosophila melanogaster and Aedes aegypti

The evolutionary divergence in receptor function suggests that while the peptide structure remains highly conserved, the downstream physiological roles may have adapted to species-specific requirements. This evolutionary pattern indicates the fundamental importance of DH31 signaling in arthropod physiology, even as its precise functions diversified.

What are the most effective protocols for recombinant expression of Dippu-DH31?

While the search results don't provide specific protocols for recombinant expression of Dippu-DH31, we can outline a methodological approach based on general peptide expression techniques and information from the search results:

• Gene Synthesis and Cloning:

  • Design codon-optimized synthetic gene based on the Dippu-DH31 sequence

  • Include appropriate tags (His-tag, GST, etc.) to facilitate purification

  • Clone into a suitable expression vector (bacterial, yeast, or insect cell system)

• Expression System Selection:

  • Bacterial systems (E. coli) may be suitable for non-glycosylated versions

  • Insect cell lines might provide more appropriate post-translational modifications

  • Consider using the baculovirus expression system if glycosylation is required

• Purification Strategy:

  • Implement a two-step purification process using affinity chromatography

  • Follow with HPLC purification to ensure high purity

  • Verify identity using mass spectrometry techniques

• Biological Activity Verification:

  • Test recombinant peptide using heterologous expression systems similar to those described in the literature for DH31 receptor activation

  • Use CHO cell luminescence assays with cells expressing the DH31 receptor

  • Compare activity to synthetic peptide standards

For N-terminal modifications, such as fluorescent labeling, the research suggests that an Alexa 488-labeled Drosophila DH31 maintained reasonable receptor activation capability, indicating that N-terminal modifications may be tolerated without significant loss of biological activity .

What assays are available for measuring DH31 activity in vitro and in vivo?

Several assays have been developed to measure DH31 activity at different levels:

• Receptor Activation Assays:

  • CHO cell-based luminescence Ca2+ mobilization assay - measures intracellular calcium release following DH31 receptor activation with EC50 values typically in the 15-30 nM range

  • cAMP production measurement in target tissues - DH31 increases cAMP in Malpighian tubules across multiple insect species

• Physiological Response Assays:

  • Fluid secretion measurement in isolated Malpighian tubules - quantifies the diuretic effect with typical EC50 values of 9.8-13 nM for Dippu-DH31 and Dippu-DH46 in D. punctata

  • Semi-isolated heart preparations - DH31 evokes increased heart rates at concentrations of 10-100 nM in crustaceans

  • Muscle contraction assays - measures the effect on hindgut, dorsal vessel, and salivary gland contractility

• In Vivo Assays:

  • Measurement of excreted urine volume following DH31 injection

  • Radio-immunoassays or enzyme immunoassays for quantifying circulating DH31 levels

  • Time-resolved fluoroimmunoassay (TR-FIA) for accurate measurement of circulating peptide levels

These assays provide complementary information about DH31 activity, from molecular interactions to whole-organism physiological responses.

How can one isolate and characterize native DH31 from insect tissues?

Isolation and characterization of native DH31 from insect tissues involves multiple steps combining biochemical, molecular, and analytical techniques:

• Tissue Preparation:

  • Dissect appropriate tissues (CNS, neurohemal organs) from Diploptera punctata

  • Extract peptides using acidified methanol or similar solvents

  • Perform initial separation using Sep-Pak C18 cartridges

• Chromatographic Purification:

  • Use reverse-phase HPLC with sequential fractionation

  • Test fractions for diuretic activity using Malpighian tubule fluid secretion assays

  • Further purify active fractions using different HPLC conditions

• Structural Analysis:

  • Determine amino acid sequence using Edman degradation or mass spectrometry

  • Confirm C-terminal amidation and other post-translational modifications

  • Synthesize the peptide based on the determined sequence for confirmation

• Activity Confirmation:

  • Compare native peptide activity with synthetic versions

  • Test on multiple physiological systems (Malpighian tubules, heart, etc.)

  • Determine EC50 values to confirm potency

• Molecular Characterization:

  • Use information from the peptide sequence to design degenerate primers

  • Clone and sequence the encoding gene

  • Analyze expression patterns using in situ hybridization and immunohistochemistry

This methodological approach has been successfully employed for the initial characterization of Dippu-DH31, as described in the search results .

How do different Dippu-DH31 concentrations affect fluid secretion in various insect species?

The effects of Dippu-DH31 on fluid secretion have been quantified across multiple insect species, revealing dose-dependent responses with species-specific characteristics:

In Diploptera punctata:

• Dippu-DH31 stimulates fluid secretion with an EC50 of 9.8 nM

• Maximum response reaches only 41% of that observed with Dippu-DH46 (EC50 13 nM)

• When applied in combination at their respective EC50 concentrations, the peptides show synergistic effects

In Locusta migratoria:

• Dippu-DH31 shows synergistic effects with both Locmi-K and Locmi-DH

• Dippu-DH46 synergizes with Locmi-K but not with Locmi-DH

• The effects are additive rather than synergistic when Dippu-DH31 and Dippu-DH46 are combined

Comparative data shows that while DH31 peptides from different species produce similar effects in receptor activation assays, their physiological effects and interactions with other diuretic peptides vary considerably between species. This suggests that the downstream signaling pathways and their integration differ among insect species, potentially reflecting adaptations to different ecological niches and water balance challenges.

What are the broader physiological roles of DH31 beyond fluid secretion regulation?

Research has revealed that DH31 plays diverse roles beyond its canonical function in diuresis:

• Myotropic Activities:

  • Cardioacceleratory effects - DH31 increases heart rate at concentrations of 10-100 nM in crustaceans

  • Stimulation of hindgut contractions - aids in waste expulsion and reduces unstirred layers around Malpighian tubules

  • Increased contractions of dorsal vessel - enhances circulation of hemolymph and hormones

  • Stimulation of salivary gland contractions - facilitates saliva release during feeding

• Feeding-Related Functions:

  • In Drosophila, DH31-expressing interendocrine cells in the midgut modulate peristalsis

  • The contractile effects on multiple tissues (salivary glands, hindgut) suggest coordination of feeding-related physiological events

• Potential Role in Ecdysis:

  • The extensive DH31 neurohemal release site in the thorax is anatomically positioned to potentially modulate stereotyped ecdysis behaviors

  • DH31 innervation of stomach muscles may be relevant since the chitinous lining of the fore and hindgut must be loosened and shed during ecdysis

• Circadian Functions:

  • In Drosophila, DH31 and its receptor are involved in temperature preference rhythms

  • DH31 receptor is expressed in clock cells, suggesting roles in circadian timing

  • PDF signaling in dorsal clock neurons expressing DH31 appears involved in wake-promoting signals

These diverse functions indicate that DH31 is a pleiotropic signaling molecule involved in coordinating multiple physiological systems, particularly those related to feeding, water balance, and rhythmic behaviors.

What are the key considerations for designing experiments to study interactions between DH31 and other hormones?

When designing experiments to study interactions between DH31 and other hormones, researchers should consider the following methodological aspects:

• Selection of Appropriate Biological Systems:

  • Choose tissues known to respond to multiple peptides (e.g., Malpighian tubules)

  • Consider species-specific differences in response patterns

  • Use both in vitro isolated organs and in vivo whole-animal approaches

• Dose-Response Relationships:

  • Establish complete dose-response curves for individual peptides

  • Use concentrations spanning several orders of magnitude (e.g., 10^-12 to 10^-6 M)

  • Determine EC50 values for each peptide individually before testing combinations

• Interaction Analysis Approaches:

  • Fixed-ratio combinations - test peptides at constant ratio but varying total concentration

  • Variable-ratio combinations - test one peptide at fixed concentration while varying the other

  • Isobolographic analysis - plot combinations producing equal effects to distinguish additive, synergistic, or antagonistic interactions

• Second Messenger Studies:

  • Measure cAMP and Ca2+ levels to understand pathway interactions

  • Use pathway inhibitors to dissect mechanisms of synergism

  • Consider temporal aspects of second messenger production

• Statistical Analysis:

  • Apply appropriate models for synergism analysis (e.g., Bliss independence model)

  • Calculate combination indices to quantify degree of synergism

  • Use factorial experimental designs to efficiently test multiple combinations

• Physiological Context:

  • Consider the physiological state of the animal (fed vs. unfed, hydrated vs. dehydrated)

  • Account for circadian factors that might influence hormone responsiveness

  • Examine interaction effects across multiple physiological parameters (fluid secretion, muscle contraction, etc.)

By carefully addressing these considerations, researchers can generate robust data on hormone interactions that provide insight into the integration of multiple signaling systems in physiological regulation.

What are the unresolved questions regarding the molecular evolution of DH31 signaling systems?

Several important questions remain regarding the molecular evolution of DH31 signaling systems:

• Receptor Diversification:

  • While insects may have undergone gene duplication for DH31 receptors, the evolutionary history and functional divergence of these receptors across arthropod lineages remain incompletely understood

  • The specialized functions of different receptor paralogs (diuresis mediated through CT/DH-R2 in R. prolixus but through CT/DH-R1 in dipterans) suggest independent evolutionary adaptations

  • The phylogenetic relationship between arthropod DH31 receptors and vertebrate calcitonin receptors needs further clarification

• Accessory Proteins:

  • Mammalian calcitonin receptors interact with receptor activity-modifying proteins (RAMPs), but these have not been identified in crustaceans and are absent from the R. prolixus genome

  • The potential existence and functions of arthropod-specific receptor component proteins remain to be investigated

  • The evolutionary implications of such auxiliary factors for receptor function require exploration

• Ligand-Receptor Co-evolution:

  • The remarkable conservation of DH31 peptides contrasts with the apparent diversification of receptor functions

  • The molecular basis for the maintenance of peptide sequence conservation despite receptor diversification needs explanation

  • The potential existence of additional, undiscovered DH31-like peptides that might interact with different receptor subtypes

Resolving these questions will require comprehensive phylogenetic analyses combined with functional characterization of DH31 signaling components across diverse arthropod species.

How might techniques like CRISPR-Cas9 be applied to study DH31 function in Diploptera punctata?

CRISPR-Cas9 genome editing offers powerful approaches for investigating DH31 function in D. punctata through various strategies:

• Gene Knockout Studies:

  • Design guide RNAs targeting the DH31 gene or its receptor

  • Create complete knockout lines to assess developmental and physiological consequences

  • Develop tissue-specific knockout systems to dissect organ-specific functions

• Reporter Gene Integration:

  • Insert fluorescent reporter genes (GFP, RFP) in-frame with DH31 or its receptor

  • Enable real-time visualization of expression patterns during development and in response to physiological challenges

  • Create split-GFP systems to visualize protein-protein interactions involving DH31 signaling components

• Point Mutations:

  • Introduce specific amino acid substitutions to identify critical residues for peptide-receptor interaction

  • Create phosphorylation site mutants to study regulation of receptor function

  • Develop mutations that modify peptide processing or secretion

• Conditional Expression Systems:

  • Develop inducible DH31 expression systems to study temporal aspects of signaling

  • Create temperature-sensitive or drug-inducible promoters to control DH31 signaling

  • Establish tissue-specific inducible expression to examine localized effects

• Methodological Considerations for D. punctata:

  • Optimize embryo microinjection techniques for this viviparous species

  • Develop appropriate screening methods for identifying edited individuals

  • Establish stable transgenic lines through careful breeding strategies

The application of CRISPR-Cas9 to D. punctata could be particularly informative given this species' established role as a model for studying endocrinology , potentially revealing new insights into the integration of DH31 signaling with other hormonal systems such as juvenile hormone regulation.

What potential applications might arise from understanding DH31 signaling in relation to insect water balance?

Understanding DH31 signaling could lead to several applications relevant to basic science and applied entomology:

• Novel Insecticide Development:

  • Design peptide mimetics that disrupt water balance by inappropriately activating or inhibiting DH31 receptors

  • Create small molecule modulators of DH31 signaling pathways as potential insect control agents

  • Develop RNA interference approaches targeting DH31 or its receptor for species-specific pest management

• Agricultural Applications:

  • Engineer crop protection strategies based on disruption of water balance in pest insects

  • Develop monitoring tools using DH31-based biosensors to detect physiological stress in beneficial insects

  • Create drought-resistant insect pollinators through modification of water balance regulation

• Biomedical Applications:

  • Use insights from DH31 signaling to better understand human calcitonin receptor function

  • Develop arthropod-derived peptide therapeutics targeting human calcitonin receptors

  • Utilize DH31-receptor interaction principles to design peptide drugs with improved receptor specificity

• Environmental Monitoring:

  • Develop biomarkers based on DH31 signaling components to assess insect stress under changing environmental conditions

  • Create biosensors using DH31 receptors to detect environmental contaminants affecting endocrine signaling

  • Monitor DH31-related gene expression as indicators of water stress in insect populations

• Fundamental Research Tools:

  • Design fluorescent DH31 analogs as tools for tracking receptor localization and internalization

  • Create optogenetic systems for spatiotemporal control of DH31 signaling

  • Develop mathematical models of water balance regulation incorporating DH31 signaling networks

These potential applications highlight the broader significance of research on insect diuretic hormone signaling beyond its immediate relevance to basic physiological understanding.